MedTrace Logo

Sequential Oxygen Therapy Strategy for Patients With COVID-19

NCT04312100 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-03-18

No results posted yet for this study

Summary

All patients with COVID-19 were divided into three groups according to their illness: mild patient who receive conventional oxygen therapy, severe patients who receive nasal high flow oxygen inhalation or non-invasive positive pressure ventilation，all the oxygen therapy will be used as part of the standard of care. Each group will enroll 10 patients, the treatment of all patients will be continuously optimized during observation, and the incidence of respiratory failure, intubation rate, 28 day mortality rate, ICU hospitalization days, etc will be recorded and analyzed so to optimize the treatment time window of sequential oxygen therapy

Conditions

  • Coronavirus Disease-2019

Interventions

OTHER

oxygen treatment

different kinds of oxygen treatments will be given to patients according to their state of illness

Sponsors & Collaborators

  • Henan Provincial People's Hospital

    lead OTHER

Principal Investigators

  • Xiaoju Zhang, PhD · Henan Provincial People's Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2020-10-31
Completion
2021-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04312100 on ClinicalTrials.gov